HUMAN PD-L2 TRIGGERS A UNIQUE T CELL INHIBITORY PROGRAM THROUGH PD-1 ENGAGEMENT DISTINCT FROM THAT OF PD-L1

被引：0
|
作者：
Srinivasamani, Anupallavi [1 ]
Curran, Michael [1 ]
Liu, Qinying [2 ]
Hegde, Shwetha [1 ]
Chen, Chao-Hsien [1 ]
Rajapakshe, Kimal [3 ]
Coarfa, Cristian
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Fudan Univ, Shanghai, Peoples R China
[3] Baylor Coll Med, Houston, TX 77030 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.233
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
233
引用
收藏
页码：A248 / A248
页数：1
相关论文
共 50 条
  • [41] TARGETING PD1/PD-L1/PD-L2 SIGNALING IN ENDOMETRIOSIS
    Mamillapalli, Ramanaiah
    Golden, Adriana
    Taylor, Hugh S.
    Gawde, Nimisha
    FERTILITY AND STERILITY, 2023, 120 (04) : E307 - E307
  • [42] PD-L2 is a second ligand for PD-1 and inhibits T cell activation
    Yvette Latchman
    Clive R. Wood
    Tatyana Chernova
    Divya Chaudhary
    Madhuri Borde
    Irene Chernova
    Yoshiko Iwai
    Andrew J. Long
    Julia A. Brown
    Raquel Nunes
    Edward A. Greenfield
    Karen Bourque
    Vassiliki A. Boussiotis
    Laura L. Carter
    Beatriz M. Carreno
    Nelly Malenkovich
    Hiroyuki Nishimura
    Taku Okazaki
    Tasuku Honjo
    Arlene H. Sharpe
    Gordon J. Freeman
    Nature Immunology, 2001, 2 : 261 - 268
  • [43] Roles of PD-L1, PD-L2 and PD-1 in Triple Negative Breast Cancers: Perspective from an Asian Cohort
    Iqbal, Jabed
    Yeong, Joe
    Lee, Bernett
    Lim, Jeffrey C. T.
    Yo, Timothy Tay Kwang
    Thike, Aye Aye
    Tan, Puay Hoon
    MODERN PATHOLOGY, 2017, 30 : 48A - 48A
  • [44] Roles of PD-L1, PD-L2 and PD-1 in Triple Negative Breast Cancers: Perspective from an Asian Cohort
    Iqbal, Jabed
    Yeong, Joe
    Lee, Bernett
    Lim, Jeffrey C. T.
    Yo, Timothy Tay Kwang
    Thike, Aye Aye
    Tan, Puay Hoon
    LABORATORY INVESTIGATION, 2017, 97 : 48A - 48A
  • [45] PD-L2 Elbows out PD-L1 to Rescue T Cell Immunity to Malaria
    Crompton, Peter D.
    Pierce, Susan K.
    IMMUNITY, 2016, 45 (02) : 231 - 233
  • [46] Intracellular Signaling triggered by engagement of PD-1 by PD-L1
    Bu, Xia
    Bu, Melissa
    Hua, Ping
    Zhu, Baogong
    Sharpe, Arlene H.
    Freeman, Gordon J.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [47] Currently Used Laboratory Methodologies for Assays Detecting PD-1, PD-L1, PD-L2 and Soluble PD-L1 in Patients with Metastatic Breast Cancer
    Jeong, Seri
    Lee, Nuri
    Park, Min-Jeong
    Jeon, Kibum
    Song, Wonkeun
    CANCERS, 2021, 13 (20)
  • [48] Robust Preanalytical Performance of Soluble PD-1, PD-L1 and PD-L2 Assessed by Sensitive ELISAs in Blood
    Krueger, Kimberly
    Mayer, Zsuzsanna
    Kottmaier, Marc
    Gerckens, Miriam
    Boeck, Stefan
    Luppa, Peter
    Holdenrieder, Stefan
    BIOMEDICINES, 2022, 10 (10)
  • [49] PD-L1 and PD-L2 expression in colorectal cancer
    Zeynep, Ozgul
    Funda, Canaz
    Evrim, Yilmaz
    Deniz, Arik
    Bulent, Yildiz
    Fatih, Yasar. N.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2023, 66 (01) : 31 - 37
  • [50] Expression of Immunomodulatory Molecules PD-1, PD-L1, and PD-L2, and their Relationship With Clinicopathologic Characteristics in Endometrial Cancer
    Sungu, Nuran
    Yildirim, Melahat
    Desdicioglu, Raziye
    Aydogdu, Ozge Basaran
    Kilicarslan, Aydan
    Dogan, Hayriye Tatli
    Yazgan, Aylin Kilic
    Akyol, Mesut
    Erdogan, Fazli
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2019, 38 (05) : 404 - 413
12345